Skip to content
Head to head

Integra Lifesciences vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: IART · ABT

Updated moments ago

1-year performance, rebased to 100

IART +13.0%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories trades cheapest on trailing earnings; Abbott Laboratories pays the highest dividend yield; Abbott Laboratories earns the most per share.
IARTABT
Snapshot
SectorMedical DevicesMedical Devices
Last price13.25103.00
Change today-2.21%-0.84%
1-year return+19.9%-15.4%
Market cap$1.03B$178.39B
52-week range8.70 – 20.4980.89 – 126.70
Valuation
P/E (TTM)77.9438.29
P/E percentile, own 5-yr range99th99th
P/B0.973.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)-6.743.72
Net profit (TTM)$-524.38M$6.44B
Revenue (TTM)$1.66B$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+2.3%+14.5%
Gross margin52.4%56.9%
Operating margin4.4%13.8%
Net margin0.8%9.7%
Free cash flow (TTM)$71.58M$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership113.6%81.2%
Insider activity (12mo)28 buy / 19 sell36 buy / 12 sell
Short interest (% of float)10.1%1.1%
Analyst consensus14% buy / 86% hold (7)93% buy / 7% hold (15)
Analyst price target$15 (+13%)$122 (+18%)
StockVane view
StockVane Quant RatingD (64)D (22)
Company
Employees4,427115,000
Founded19891900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.